Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population

Objectives. To quantify the risk of cancer and compare it with that for the general population in a modern cohort of UK patients with RA and to identify risk factors for cancer among this cohort. Methods. The study population comprised biologic-naïve RA subjects receiving non-biologic disease-modify...

Descripción completa

Detalles Bibliográficos
Autores principales: Mercer, Louise K., Davies, Rebecca, Galloway, James B., Low, Audrey, Lunt, Mark, Dixon, William G., Watson, Kath D., Symmons, Deborah P. M., Hyrich, Kimme L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521445/
https://www.ncbi.nlm.nih.gov/pubmed/23238979
http://dx.doi.org/10.1093/rheumatology/kes350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521445/
https://www.ncbi.nlm.nih.gov/pubmed/23238979
http://dx.doi.org/10.1093/rheumatology/kes350

Ejemplares similares